United States : CTI BioPharma Announces Outcome From End-of-Phase-2a Meeting With U.S. Food and Drug Administration (FDA) Regarding Pacritinib for Treatment of Myelofibrosis

Press/Media

Period20 Jul 2019

Media coverage

1

Media coverage

  • TitleUnited States : CTI BioPharma Announces Outcome From End-of-Phase-2a Meeting With U.S. Food and Drug Administration (FDA) Regarding Pacritinib for Treatment of Myelofibrosis
    Media name/outletTendersInfo – News
    Country/TerritoryIndia
    Date20/07/19
    PersonsJohn Mascarenhas